Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Marks

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|December 3, 2021
Clarifying US regulations on xenotransplantationPeter Marks, Steven Solomon
Transfusion|June 21, 2019
Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002)Peter Marks, Nicole Verdun
The New England Journal of Medicine|October 10, 2019
Drug Regulation in the Era of Individualized TherapiesJanet Woodcock, Peter Marks
Gene Therapy|April 4, 2020
Toward a new framework for the development of individualized therapiesPeter Marks, Celia Witten
JAMA|January 5, 2024
Is Vaccination Approaching a Dangerous Tipping Point?Peter Marks, Robert Califf
The New England Journal of Medicine|March 8, 2018
Balancing Safety and Innovation for Cell-Based Regenerative MedicinePeter Marks, Scott Gottlieb
European Journal of Gastroenterology & Hepatology|February 21, 2012
Calorie and alcohol consumption in nonalcoholic fatty liver diseasePeter Marks, Roger Williams
Journal of the Royal Society of Medicine|May 2, 2002
Emergency ambulance triagePeter Marks, Tim Daniel
The New England Journal of Medicine|January 24, 2024
Secondary Cancers after Chimeric Antigen Receptor T-Cell TherapyNicole Verdun, Peter Marks
The Hastings Center Report|July 22, 2014
When a blood donor has sickle cell trait: incidental findings and public healthLisa M Lee, Peter Marks
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|December 3, 2021
Clarifying US regulations on xenotransplantationPeter Marks, Steven Solomon
Transfusion|June 21, 2019
Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002)Peter Marks, Nicole Verdun
The New England Journal of Medicine|October 10, 2019
Drug Regulation in the Era of Individualized TherapiesJanet Woodcock, Peter Marks
Gene Therapy|April 4, 2020
Toward a new framework for the development of individualized therapiesPeter Marks, Celia Witten
JAMA|January 5, 2024
Is Vaccination Approaching a Dangerous Tipping Point?Peter Marks, Robert Califf
The New England Journal of Medicine|March 8, 2018
Balancing Safety and Innovation for Cell-Based Regenerative MedicinePeter Marks, Scott Gottlieb
European Journal of Gastroenterology & Hepatology|February 21, 2012
Calorie and alcohol consumption in nonalcoholic fatty liver diseasePeter Marks, Roger Williams
Journal of the Royal Society of Medicine|May 2, 2002
Emergency ambulance triagePeter Marks, Tim Daniel
The New England Journal of Medicine|January 24, 2024
Secondary Cancers after Chimeric Antigen Receptor T-Cell TherapyNicole Verdun, Peter Marks
The Hastings Center Report|July 22, 2014
When a blood donor has sickle cell trait: incidental findings and public healthLisa M Lee, Peter Marks
Pageof 7